Leal Therapeutics
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $105M
Investors
- 8
About Leal Therapeutics
Based in Massachusetts, US, and founded in 2021 by CEO Asa Abeliovich, Leal Therapeutics, Inc. specializes in creating therapeutics for central nervous system disorders. In August 2026, Leal Therapeutics, Inc. The company provides a wide range of therapeutic products aimed at CNS disorders, including lipid metabolism-targeting LTX-002 for ALS and Alzheimer’s, presynaptic glutamate modulator LTX-001 for schizophrenia and ALS, and complement pathway inhibitor LTX-003 for Alzheimer’s and FTD. Additionally, the firm also provides investigational ASO-based therapies like LTX-004 for lipid trafficking in dementia-related conditions and LTX-005 targeting NMDAR in refractory epilepsy and treatment-resistant depression. The company's solutions are marketed primarily in North America and select regions in Europe, targeting diverse clientele across public and private healthcare institutions. Leal Therapeutics, Inc. generates revenue through a combination of subscription-based models and direct service contracts with healthcare providers. Clients enter into annual subscription agreements granting them access to the company's software platforms and continuous updates, featuring tiered pricing plans that cater to different sizes of healthcare organizations.
Who invested in Leal Therapeutics
8 investors across 3 rounds
See all investors in Leal Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leal Therapeutics
Who invested in Leal Therapeutics?
Leal Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leal Therapeutics raised?
Leal Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Leal Therapeutics last raise money?
Leal Therapeutics's most recent round on record is a Series A, in Aug 2026.
What does Leal Therapeutics do?
Based in Massachusetts, US, and founded in 2021 by CEO Asa Abeliovich, Leal Therapeutics, Inc.
Where is Leal Therapeutics headquartered?
Leal Therapeutics is headquartered in Worcester, US.
Which VCs invest in companies like Leal Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Leal Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Leal Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.